Qué pesaítos ya... Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/He5yCDSW6a a través de @JAMA_current part of @JAMANetwork
@matteosalvinimi Capitò apri il link, usa google traduttore (lo sappiamo che non sai lì inglese) fatti spiegare il significato di quello che c'è scritto e poi con l'idrossiclorichina facci i gargarismi. Pagliaccio #COVID19 #HydroxyChloroquine https://t.c
RT @GermHunterMD: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 HCQ still doesn’t wor…
RT @GermHunterMD: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 HCQ still doesn’t wor…
RT @GermHunterMD: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 HCQ still doesn’t wor…
RT @GermHunterMD: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 HCQ still doesn’t wor…
RT @GermHunterMD: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 HCQ still doesn’t wor…
RT @GermHunterMD: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 HCQ still doesn’t wor…
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 HCQ still doesn’t work. The only surprise is that HCQ trials are still being published in top tier journals https://t.co/F6NK3BRp4K https://t.co/CADT1HcZL
Finally: Hydroxychloroquine RCT results. Summary: no benefit BUT no harm. In other words, it’s the essential oils of COVID treatments. Good thing Utah got its money back. #utpol #utleg https://t.co/De205547ze
RT @ABsteward: 🔥The National Heart, Lung, and Blood Institute PETAL Clinical Trials Network🔥 Effect of Hydroxychloroquine on Clinical Statu…
hydroxychloroquine does not improve outcomes in hospitalized COVID-19 patients https://t.co/kAJnJF5dwt
Day job results: ORCHID trial final results consistent with the press release. Definitive answer on hydroxychloroquine and a reminder that placebo-controlled trials can be done even in a pandemic. https://t.co/CqGRJhTHdy
I'm incredibly proud of the women and men of PETAL and grateful for the collaboration of patients and their families in answering this question robustly and definitively. ORCHID is published today in JAMA. No benefit _and no harm_ for COVID inpatients. htt
🔥The National Heart, Lung, and Blood Institute PETAL Clinical Trials Network🔥 Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With #COVID19 https://t.co/Een39ksvGe via @JAMA_current part of @JAMANetwork https://t.co/clz